Imperial College London
Trending Articles
Related Content
Research & Development
EnteroBiotix partners with Imperial College London on microbiome therapeutics
Partnership includes a Phase II clinical trial using microbiome therapeutics funded by the Medical Research Council (MRC) aiming to potentiate allo-HCT in patients suffering from haematological malignancy